Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MENINGOCOCCAL INFECTION”

361 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 361 results

Large-scale testing (Phase 3)UnknownNCT04689191
What this trial is testing

A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Post-approval studies (Phase 4)Study completedNCT00271479
What this trial is testing

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Infections, MeningococcalMeningitis, Meningococcic
Epicentre 720
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Post-approval studies (Phase 4)Study completedNCT03274102
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 780
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT01934140
What this trial is testing

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Who this might be right for
Infections, Meningococcal
Pfizer 311
Testing effectiveness (Phase 2)Study completedNCT00427908
What this trial is testing

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 613
Testing effectiveness (Phase 2)Study completedNCT01992536
What this trial is testing

Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)

Who this might be right for
Meningococcal Disease
Novartis Vaccines 194
Post-approval studies (Phase 4)Study completedNCT00392808
What this trial is testing

Immunogenicity of the Booster Dose of Two MenC Vaccines

Who this might be right for
Meningococcal Infection
Centro Superior de Investigación en Salud Publica 389
Testing effectiveness (Phase 2)Study completedNCT00808028
What this trial is testing

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Who this might be right for
Meningitis, Meningococcal
Pfizer 538
Post-approval studies (Phase 4)Study completedNCT02569632
What this trial is testing

Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Who this might be right for
Meningococcal Infections
UCSF Benioff Children's Hospital Oakland 18
Large-scale testing (Phase 3)Study completedNCT00974363
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 697
Testing effectiveness (Phase 2)Study completedNCT00258856
What this trial is testing

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 234
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT02199691
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,715
Testing effectiveness (Phase 2)Study completedNCT01026974
What this trial is testing

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Who this might be right for
Meningococcal Disease
Novartis Vaccines 120
Large-scale testing (Phase 3)Study completedNCT01717638
What this trial is testing

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 805
Not applicableUnknownNCT04023929
What this trial is testing

Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays

Who this might be right for
PertussisMeningococcal DiseasePrematurity
St George's, University of London 45
Not applicableStudy completedNCT01984125
What this trial is testing

Testing the Use of Prompts to Increase Adolescent Immunization Rates

Who this might be right for
Vaccine Preventable DiseasesMeningococcal DiseaseHuman Papillomavirus+2 more
University of California, Los Angeles 7,040
Next Page